Assure (IONM) Competitors $0.03 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsTrendsBuy This Stock IONM vs. SONX, BIOL, STSS, HSDT, AFIB, BRSH, SDCCQ, GMVDF, VRAYQ, and AHPIShould you be buying Assure stock or one of its competitors? The main competitors of Assure include Sonendo (SONX), BIOLASE (BIOL), Sharps Technology (STSS), Helius Medical Technologies (HSDT), Acutus Medical (AFIB), Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), ViewRay (VRAYQ), and Allied Healthcare Products (AHPI). These companies are all part of the "medical equipment" industry. Assure vs. Its Competitors Sonendo BIOLASE Sharps Technology Helius Medical Technologies Acutus Medical Bruush Oral Care SmileDirectClub G Medical Innovations ViewRay Allied Healthcare Products Assure (NASDAQ:IONM) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment. Which has more risk and volatility, IONM or SONX? Assure has a beta of 190.36, meaning that its stock price is 18,936% more volatile than the S&P 500. Comparatively, Sonendo has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500. Do institutionals and insiders hold more shares of IONM or SONX? 3.3% of Assure shares are owned by institutional investors. Comparatively, 28.7% of Sonendo shares are owned by institutional investors. 3.8% of Assure shares are owned by insiders. Comparatively, 7.9% of Sonendo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is IONM or SONX more profitable? Sonendo has a net margin of -92.74% compared to Assure's net margin of -25,178.32%. Assure's return on equity of 0.00% beat Sonendo's return on equity.Company Net Margins Return on Equity Return on Assets Assure-25,178.32% N/A -249.78% Sonendo -92.74%-184.01%-68.60% Does the media prefer IONM or SONX? In the previous week, Assure's average media sentiment score of 0.00 equaled Sonendo'saverage media sentiment score. Company Overall Sentiment Assure Neutral Sonendo Neutral Which has higher valuation & earnings, IONM or SONX? Assure has higher earnings, but lower revenue than Sonendo. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAssure$149K0.61-$26.08MN/AN/ASonendo$44.40M0.01-$60.92M-$59.12-0.02 SummarySonendo beats Assure on 5 of the 9 factors compared between the two stocks. Get Assure News Delivered to You Automatically Sign up to receive the latest news and ratings for IONM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IONM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IONM vs. The Competition Export to ExcelMetricAssureSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$91K$256.84M$5.56B$9.04BDividend YieldN/AN/A5.24%4.01%P/E RatioN/A5.9227.6420.24Price / Sales0.6173.84416.55117.31Price / CashN/A196.1236.8958.10Price / Book0.006.338.035.67Net Income-$26.08M-$27.18M$3.18B$249.21M7 Day PerformanceN/A0.60%2.93%3.28%1 Month PerformanceN/A-6.65%1.72%3.95%1 Year PerformanceN/A25.56%34.39%20.98% Assure Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IONMAssureN/A$0.03flatN/A-99.5%$91K$149K0.00130SONXSonendoN/A$1.15flatN/AN/A$493K$44.40M-0.02250BIOLBIOLASE1.0184 of 5 stars$0.01-8.3%$1.20+10,789.3%-88.5%$368K$48.83M0.00160News CoverageGap UpSTSSSharps Technology0.0958 of 5 stars$5.57-2.3%N/AN/A$301KN/A0.003HSDTHelius Medical Technologies0.6515 of 5 stars$0.32-2.8%N/A-98.6%$167K$520K-0.0130Stock SplitAFIBAcutus MedicalN/A$0.00flatN/AN/A$98K$7.16M0.00340BRSHBruush Oral CareN/AN/AN/AN/A$44K$2.92M0.0011Gap DownSDCCQSmileDirectClubN/A$0.00-50.0%N/AN/A$40K$470.74M0.002,700Gap UpGMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16K$27.05M0.00150Gap Up Related Companies and Tools Related Companies SONX Alternatives BIOL Alternatives STSS Alternatives HSDT Alternatives AFIB Alternatives BRSH Alternatives SDCCQ Alternatives GMVDF Alternatives VRAYQ Alternatives AHPI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IONM) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assure Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Assure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.